<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>HEPC_J</title>
    <meta name="title" content="NHANES 2017-2018: Hepatitis C: RNA (HCV-RNA), Confirmed Antibody (INNO-LIA), &amp; Genotype Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXHCR">LBXHCR - Hepatitis C RNA</a>
              </li>
              <li>
                <a href="#LBDHCI">LBDHCI - Hepatitis C Antibody (confirmed)</a>
              </li>
              <li>
                <a href="#LBXHCG">LBXHCG - Hepatitis C Genotype</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2017-2018 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Hepatitis C: RNA (HCV-RNA), Confirmed Antibody (INNO-LIA), &amp; Genotype (HEPC_J)</h3>
        <h4> Data File: HEPC_J.xpt</h4>
        <h5 class="left">First Published: February 2020</h5>
        <h5 class="right">Last Revised: May 2022</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Hepatitis viruses
constitute a major public health problem because of the morbidity and mortality
associated with the acute and chronic consequences of these infections. New immunization
strategies have been developed to eliminate the spread of hepatitis B virus
(HBV) and hepatitis A virus (HAV) in the United States. Recommendations have
also been developed for the prevention and control of hepatitis C virus (HCV)
infection. Because of the high rate of asymptomatic infection with these
viruses, information about the prevalence of these diseases is needed to
monitor prevention efforts. By testing a nationally representative sample of
the U.S. population, NHANES will provide the most reliable estimates of
age-specific prevalence needed to evaluate the effectiveness of the strategies
to prevent these infections. In addition, NHANES provides the means to better
define the epidemiology of other hepatitis viruses. NHANES testing for markers
of infection with hepatitis viruses will be used to determine secular trends in
infection rates across most age and racial/ethnic groups, and will provide a
national picture of the epidemiologic determinants of these infections.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">In 2013, CDC
revised its guidelines for Hepatitis C (HCV) testing because of 1) changes in
the availability of certain commercial HCV antibody tests; 2) evidence that
many persons who are identified as reactive by an HCV antibody test might not
subsequently be evaluated to determine if they have current HCV infection; and
3) there have been significant advances in the development of antiviral agents
with improved efficacy against HCV.<sup>1</sup></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The flow chart for
the new Hepatitis C algorithm can be found in the laboratory method file or by
following the MMWR link below.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><a href="https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf"><span style="color: #003399;">https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf</span></a></p><h2 id="Eligible_Sample">Eligible Sample</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Examined
participants aged 6 years and older were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis C RNA
(HCV-RNA)</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The COBAS AMPLICOR
HCV MONITOR Test, version 2 0 (v2.0) is an in vitro nucleic acid amplification
test for the quantitation of Hepatitis C Virus RNA in human serum or plasma on
the COBAS AMPLICOR Analyzer.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis C Confirmed
Antibody (INNO-LIA)</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">In 2012 and
earlier years, the hepatitis C virus testing algorithm began with an antibody
screening test, and antibody screening reactive samples were then tested with a
recombinant/synthetic immunoblot assay as the antibody confirmation test.
Samples with positive antibody confirmation results were then tested with a
nucleic acid amplification test for hepatitis C virus RNA. HCV-RNA positive
samples were then tested with a line probe assay to determine the virus
genotype from six genotypes, and subtype for genotype 1, the most prevalent
genotype in the U.S. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Beginning in 2013,
samples reactive to the antibody screening test were first tested for RNA.
Then, all RNA positive samples were tested for genotype, and only RNA negative
samples were tested with an antibody confirmation test. This change in the
testing algorithm was made to align the NHANES HCV testing algorithm with a
2013 update to CDC&rsquo;s guidance on testing for HCV infection by clinicians and
laboratorians. Additionally, the antibody confirmation test changed to a 3rd
generation line immunoassay in 2013 because the test used in 2012 and earlier
was no longer commercially available and the stored supply of these test kits
had been exhausted. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">For the antibody
confirmation test, the manual 16-hour sample incubation test procedure is used.
10ul of specimens and controls are diluted in 1mL diluent in test troughs to
ensure test strips will slide easily and remain submerged during incubation.
Specimens and controls are incubated with agitation by rocker at 34 rpm
overnight (16&plusmn;2 hours) at room temperature (18&ndash;25&deg;). After a 3X/5min each wash
step on microtiter plate shaker, conjugate is added with a 30-minute incubation
at room temperature, followed by aspiration, 3X/5min each wash step and
30-minute incubation in substrate solution also on microtiter plate shaker.
Finally, strips are agitated with stop solution for 10&ndash;30 minutes at room
temperature. The microtiter plate shaker is set for 160 rpm and used for all
the washes and solution incubations. Strips are then dried completely in a dry
incubator at 37&deg;C for 30 minutes then mounted on the line immunoassay score
data reporting sheet with inverted tape for reading within one hour using the
reading card. The strips have lines for a background control, three reference
lines for antibody (level &plusmn;, human IgG, weak positive; level 1+ human IgG,
moderate positive; and level 3+, anti-human Ig, strong positive), and six lines
for HCV antigens (C1, C2, E2, NS3, NS4, and NS5). Samples with a positive
antibody confirmation test result are reported as positive. Samples with a
negative antibody confirmation test result are reported as negative. Samples
with an indeterminate antibody confirmation test result are released as
missing. Only specimens insufficient in quantity are deemed indeterminate.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Hepatitis C
genotype</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The VERSANT &reg; HCV
Genotype 2.0 Assay (LiPA) is a line probe assay designed to identify Hepatitis
C virus (HCV) genotypes 1 to 6 in human serum or EDTA plasma samples. Subtype
information is available in the majority of cases. </p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the
Laboratory Method Files section for a detailed description of the laboratory
methods used.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There were no
changes to the lab method, lab equipment, or lab site for this component in the
NHANES 2017-2018 cycle.</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPC-J-MET-HEPATITIS-C-ANTIBODY-CONFIRMED-508.pdf">Hepatitis C Confirmed Antibody Laboratory Procedure Manual</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPC-J-MET-HEPATITIS-C-GENOTYPE-508.pdf">Hepatitis C Genotype Laboratory Procedure Manual</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/HEPC-J-MET-HEPATITIS-C-RNA-508.pdf">Hepatitis C RNA Laboratory Procedure Manual</a>
          <span> (February 2020)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Serum samples were
processed, stored, and shipped to the Division of Viral Hepatitis, National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, Atlanta, GA for analysis.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Detailed instructions
on specimen collection and processing are discussed in the NHANES <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf"><span style="color: #003399;">Laboratory Procedures Manual (LPM)</span></a>. Vials are stored under appropriate frozen (&ndash;30&deg;C) conditions until they
are shipped to Division of Viral Hepatitis, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention for testing.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory
Improvement Act mandates. Detailed QA/QC instructions are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf"><span style="color: #003399;">NHANES LPM</span></a>.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Mobile Examination
Centers (MECs) </b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured competency assessment evaluation during visits to
evaluate both the quality of the laboratory work and the quality-control
procedures. Each laboratory staff member is observed for equipment operation,
specimen collection and preparation; testing procedures and constructive
feedback are given to each staff member. Formal retraining sessions are
conducted annually to ensure that required skill levels were maintained.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Analytical
Laboratories</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">
NHANES
uses several methods to monitor the quality of the analyses performed by the
contract laboratories. In the MEC, these methods include performing blind split
samples collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories
randomly perform repeat testing on 2% of all specimens.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The data were
reviewed. Incomplete data or improbable values were sent to the performing
laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the 2<a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017">017-2018 Laboratory Data Overview</a> for general
information on NHANES laboratory data.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. For example, in 2017-2018, approximately 80% of children aged 1-17 years who were examined in the MEC provided a blood specimen through phlebotomy, while 95% of examined adults age 18 and older provided a blood specimen.&nbsp; Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Please refer to
the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic
Guidelines </a>and the on-line NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx">Tutorial</a> for further details on the use of sample weights and other analytic
issues.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Demographic and
Other Related Variables</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The analysis of
NHANES laboratory data must be conducted using the appropriate survey design
and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2017">NHANES 2017-2018
Demographics File</a> contains demographic data, health indicators, and
other related information collected during household interviews as well as the
sample design variables. The recommended procedure for variance estimation
requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively)
in the demographic data file.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This laboratory
data file can be linked to the other NHANES data files using the unique survey
participant identifier (i.e., SEQN).</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><b>Detection Limits</b></p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This data is
qualitative. The use of lower limits of detection (LLODs) is not applicable.</p>
<p style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Exam sample
weights should be used for analyses. </p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(No. RR-19):1-39. Available from: <a href="https://www.cdc.gov/mmwr/PDF/RR/RR4719.pdf">https://www.cdc.gov/mmwr/PDF/RR/RR4719.pdf</a></li>
          <li>Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR. 2012;61(RR-4):1-32. Available from: <a href="http://www.cdc.gov/mmwr/pdf/rr/rr6104.pdf">http://www.cdc.gov/mmwr/pdf/rr/rr6104.pdf</a></li>
          <li>Centers for Disease Control and Prevention. Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians. MMWR. 2013; 62 Early Release:1-4. Available from: <a href="https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf">https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf</a></li>
          <li>Moyer VA. Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2013;159(5):349-357. Available from: <a href="https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-c-screening">https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-c-screening</a></li>
          <li>Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorian. Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. May 7, 2013. &lt;<a href="https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf">https://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf</a>&gt;</li>
          <li>World Health Organization. Prequalification of In Vitro Diagnostics Public Report: INNO-LIA HCV Score. PPQDx 0202-073-00. July 24, 2015. Available from: <a href="http://www.who.int/diagnostics_laboratory/evaluations/150729_final_report_0202_073_00_hcv.pdf">http://www.who.int/diagnostics_laboratory/evaluations/150729_final_report_0202_073_00_hcv.pdf</a></li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHCR">LBXHCR - Hepatitis C RNA</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHCR</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis C RNA</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis C RNA</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">51</td>
                <td class="values" align="right">51</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">98</td>
                <td class="values" align="right">149</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Negative Screening HCV Antibody</td>
                <td class="values" align="right">6541</td>
                <td class="values" align="right">6690</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">745</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHCI">LBDHCI - Hepatitis C Antibody (confirmed)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHCI</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis C Antibody (confirmed)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis C Antibody (confirmed)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">54</td>
                <td class="values" align="right">54</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">33</td>
                <td class="values" align="right">87</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Negative Screening HCV Antibody</td>
                <td class="values" align="right">6541</td>
                <td class="values" align="right">6628</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">4</td>
                <td class="values">Positive HCV RNA</td>
                <td class="values" align="right">51</td>
                <td class="values" align="right">6679</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">756</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHCG">LBXHCG - Hepatitis C Genotype</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHCG</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis C Genotype</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis C Genotype</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Genotype 1a</td>
                <td class="values" align="right">25</td>
                <td class="values" align="right">25</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Genotype 1b</td>
                <td class="values" align="right">7</td>
                <td class="values" align="right">32</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Gen 1 other than a/b/not determined</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">33</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">4</td>
                <td class="values">Genotype 2</td>
                <td class="values" align="right">6</td>
                <td class="values" align="right">39</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">5</td>
                <td class="values">Genotype 3</td>
                <td class="values" align="right">6</td>
                <td class="values" align="right">45</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">6</td>
                <td class="values">Genotype 4</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">46</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">7</td>
                <td class="values">Genotype 5</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">46</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">8</td>
                <td class="values">Genotype 6</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">47</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">9</td>
                <td class="values">Genotype undetermined</td>
                <td class="values" align="right">2</td>
                <td class="values" align="right">49</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">7386</td>
                <td class="values" align="right">7435</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>